Last reviewed · How we verify
NCT05661175
Application of One-handed Lithotripsy in Percutaneous Nephrolithotomy
NA trial testing one-handed technique in Percutaneous Nephrolithotomy in 100 participants. Status unknown.
3 November 2023
Quick facts
| Lead sponsor | The First Affiliated Hospital of University of South China |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | treatment |
| Enrollment | 100 |
| Start date | 3 December 2022 |
| Primary completion | 3 November 2023 |
| Estimated completion | 3 November 2023 |
| Sites | 1 location across China |
Drugs / interventions tested
- one-handed technique
Conditions studied
- Percutaneous Nephrolithotomy — all drugs for Percutaneous Nephrolithotomy →
Sponsor
The First Affiliated Hospital of University of South China
Who can join
Adults 18 to 80, any sex, with Percutaneous Nephrolithotomy. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Percutaneous nephrolithotomy(PCNL) is a surgical method for upper urinary calculi.Traditional percutaneous nephrolithotomy usually requires the lithotripsy with the left hand holding the nephroscope and the right hand adjusting the laser fiber,which requires a lot of practice to master this technique.The goal of this study is to explore the safety and effectiveness of the PCNL with one-handed lithotripsy technique
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT05661175
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Percutaneous Nephrolithotomy
Currently open trials in the same condition.
- NCT07326670 — Effects of Spinal vs General Anesthesia on Systemic Inflammation in PCNL · recruiting
- NCT07203859 — The Effectiveness of Quadro İliac Plane Block in Percutaneous Nephrolithotomies · NA · active not recruiting
- NCT07363681 — Inhalational Agents Versus Dexmedetomidine for Maintenance of General Anesthesia · NA · recruiting
- NCT06393062 — Gram Stain of the First Urine After Puncture in Percutaneous Nephrolithotomy · NA · recruiting
- NCT05574517 — Tubeless Percutaneous Nephrolithotomy Without Reverse Insertion of a Ureteral Catheter · NA · recruiting
Other The First Affiliated Hospital of University of South China trials
Trials by the same sponsor.
- NCT07147335 — The Role of Serum AKR1B10 in Early Warning of Hepatocellular Carcinoma in Cirrhosis Patients · recruiting
- NCT06979037 — Genetic Markers of Diabetic Ulcers and Personalized Treatment Targets Research · recruiting
- NCT06492811 — Efficacy and Safety of a Hydrogel Containing Cascade Catalytic Enzymes in the Treatment of Diabetic Wounds · Phase 2 · active not recruiting
- NCT05755594 — A Prospective Study on the Safety and Efficacy of Robot-assisted Pancreaticoduodenectomy · NA · not yet recruiting
- NCT05755607 — A Multicenter Prospective Randomized Controlled Study of RPD Versus LPD · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05661175 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by The First Affiliated Hospital of University of South China
- Last refreshed: 28 March 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05661175.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing